You have been asked to design a drug to inhibit bcr-abl in an effort to treat cml. using your knowledge of enzyme catalyzed reactions and the bcr-abl kinase, propose a drug development strategy to combat cml.

answers are:

lysogenic     viral dna merges with host cell dna

lysogenic     no symptoms

lytic               viral dna takes over

lysogenic     virus does not destroy host cell

lytic               virus destroys host cell

lytic               induces symptoms of viral infection

lysogenic       cell reproduces and spreads provirus

-hails tea

explanation:

-t poses